EUTM file information

018695932

CODRP


May 1, 2022

Trademark Summary

The trademark application CODRP was filed by MBD Co., Ltd., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on June 16, 2022, and still open for oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 10 with following description of goods:
    1. Medical measuring device for cancer diagnosis
    2. Cancer diagnosis kit
    3. Medical measuring device for testing to predict anticancer drug sensitivity
    4. Test kit for predicting anticancer drug sensitivity
    5. Test tools for predicting anti-cancer drug sensitivity
    6. Medical measuring device for testing to predict radiation sensitivity for medical use
    7. Test kit for predicting radiation sensitivity for medical use
    8. Test tools for predicting radiation sensitivity for medical use
    9. Diagnostic kit for medical experiments
    10. Clinical diagnostic kit.
  • The mark was filed in class 42 with following description of goods:
    1. Genetic testing for scientific research purposes
    2. DNA analysis for scientific research purposes
    3. Research related to biotechnology
    4. Cancer research
    5. Medical scientific research in the field of cancer disease
    6. Medical scientific research
    7. Clinical laboratory.
  • The mark was filed in class 44 with following description of goods:
    1. Medical analysis for cancer diagnosis and prognosis
    2. Information provider in the field of cancer prevention/test/diagnosis/treatment
    3. Medical test for diagnosis or treatment
    4. Medical analysis for predicting anticancer drug sensitivity
    5. Medical analysis for predicting radiation sensitivity for medical use.
Trademarkers